André Dallmann
ORCID: 0000-0003-1108-5719Also affiliated with Bayer (United States), Humboldt-Universität zu Berlin, Clinique Claude-Bernard, Bayer (France)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 4 papers. Top paper: “Mechanistic Modeling of the Drug‐Drug Interaction Between Efavirenz and Dolutegravir: Is This Interaction Clinically Relevant When Switching From Efavirenz to Dolutegravir During Pregnancy?”.
John van den Anker, Homa K. Ahmadzia, Natella Rakhmanina, André Dallmann
Russell E. Ware, André Dallmann, Alexander A. Vinks, Min Dong
Dionna J. Green, John van den Anker, Joaquin Calderon, Homa K. Ahmadzia, Gilbert J. Burckart +2 more
Denise Feick, Pavel Balazki, Salih Benamara, Rolf Burghaus, Marylore Chenel +27 more